|
|
|
Insider
Information: |
Lin Patrick |
Relationship: |
|
City: |
Hanover |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
29,059 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$6,538 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
29,059 |
|
|
Total
Value |
$6,538 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Processa Pharmaceuticals, Inc. |
PCSA |
|
2024-07-10 |
29,059 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy Off |
|
2024-07-10 |
4 |
D |
$1.71 |
$463 |
D/D |
(271) |
29,059 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy Off |
|
2024-07-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
644 |
29,330 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy Off |
|
2024-04-05 |
4 |
D |
$2.79 |
$1,504 |
D/D |
(539) |
28,686 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy Off |
|
2024-04-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,675 |
29,225 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy Off |
|
2024-02-01 |
4 |
B |
$2.40 |
$3,600 |
D/D |
1,500 |
27,478 |
0.01 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy Off |
|
2024-01-31 |
4 |
B |
$2.37 |
$5,925 |
D/D |
2,500 |
25,978 |
0.01 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy Off |
|
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,675 |
29,153 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy Off |
|
2024-01-01 |
4 |
D |
$2.79 |
$1,504 |
D/D |
(539) |
28,614 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy Off |
|
2023-10-12 |
4 |
A |
$0.32 |
$1,600 |
D/D |
5,000 |
469,535 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy Off |
|
2023-10-10 |
4 |
A |
$0.21 |
$2,877 |
D/D |
13,700 |
464,535 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy Off |
|
2023-02-09 |
4 |
A |
$0.80 |
$10,000 |
D/D |
12,500 |
450,835 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy Off |
|
2022-08-05 |
4 |
D |
$3.17 |
$8,420 |
D/D |
(2,656) |
438,335 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy Off |
|
2022-08-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,601 |
440,991 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy Off |
|
2022-05-17 |
4 |
B |
$1.59 |
$3,189 |
D/D |
2,000 |
433,390 |
2.66 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy Off |
|
2022-04-07 |
4 |
B |
$3.54 |
$2,835 |
D/D |
800 |
431,390 |
2.66 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy Off |
|
2022-04-06 |
4 |
B |
$3.13 |
$3,752 |
D/D |
1,200 |
430,590 |
2.66 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy Off |
|
2021-12-14 |
4 |
B |
$4.00 |
$12,000 |
D/D |
3,000 |
429,390 |
2.74 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy Off |
|
2021-12-03 |
4 |
B |
$4.80 |
$16,795 |
D/D |
3,500 |
426,390 |
2.74 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy Off |
|
2021-08-26 |
4 |
B |
$6.02 |
$24,088 |
D/D |
4,000 |
422,890 |
2.74 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy Off |
|
2021-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
7,601 |
418,890 |
0 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy Off |
|
2021-06-21 |
4 |
B |
$6.65 |
$13,300 |
D/D |
2,000 |
401,737 |
2.74 |
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy OffO |
|
2020-10-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
368,487 |
|
- |
|
PCSA |
Processa Pharmaceuticals,... |
Chief Business - Strategy Off |
|
2020-10-01 |
4 |
B |
$2.10 |
$65,625 |
D/D |
31,250 |
399,737 |
2.74 |
- |
|
23 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|